LimmaTech has leveraged a novel technology platform to produce a pipeline of vaccines against multi-resistant bacterial infections that present global health threatsSCHLIEREN, Switzerland (BUSINESS WIRE) LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threate.